Support Science Technology Engineering and Math Education/H-1B related provisions in any immigration reform measure Address concerns with India trade/Intellectual Property policies. Address concerns regarding biomedical corporate mergers and acquisitions. Support NIH research funding. Support Viral Hepatitis Testing Act. Support repeal of medical device tax. Support extension of Therapeutic Discovery Tax Credit and R&D credit. Oppose repeal of Orphan Drug Tax Credit Address concerns with provisions of patent litigation reform, including Covered Business Method patents. Health care reform implementation; the 340B program of the Health Resources and Services Administration (HRSA), specifically 340B drug pricing program issues, including program expansion and specific issues include: HRSA oversight, definition of patient, the Affordable Care Act's expansion of covered 340B entities. Support legislation increasing access to wireless technologies. FDA review process consistency and predictability. Address concerns with Medicare Independent Payment Advisory Board (IPAB).Address concerns with changes to Medicare Part B and Part D programs. Issues related to antibiotics and breakpoints. Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints; antibiotic resistance among elderly population; reimbursement issues for antibiotics. H.R. 4187, DISARM - Developing An Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014; President's Council of Advisors on Science and Technology (PCAST) and their recent report on antibiotic resistance. HR 4302 Protecting Access to Medicare Act of 2014 - Public Law No: 113-93
In the above the specific issues included potential Medicare offsets that might be applied to prescription drugs
H.R. 4187 - Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014. 
Issues relating to Medicare reimbursement of antibioticsAddress concerns with Medicare Independent Payment Advisory Board (IPAB). Addresss concerns with changes to Medicare Part B and Part D programs, and 2015 Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support Treat and Reduce Obesity Act. FY 2014 Omnibus HR 3547; FY 2014 Continuing Resolution H J Res 106 PL 113-73
FY 2014 Continuing Resolution H J Res 59 PL 113-67; FY 2015 Budget, H Con Res 96 (no Senate Companion at this time) 
HJ Res 124 Continuing Appropriations Resolution, 2015In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs.

Labor/HHS/Ed Appropriations: National Institutes of Health, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; Food and Drug Administration Appropriations; Patent and Trademark Office Appropriations Implementation of the "GAIN" provisions/Title VIII of the Food and Drug Administration Safety and Innovation Act (FDASIA) - PL 112-144; antibiotic product development incentive, limited population antibiotic product (LPAD) and breakpoint legislation; HR 3742- the Antibiotic Development to Advance Patient Treatment Act of 2013; H.R. 4187 - Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014;antibiotic product incentives for possible inclusion in the House "21st Century Cures" effort
IMM - Immigration TRD - Trade (domestic/foreign) FIN - Financial Institutions/Investments/Securities MED - Medical/Disease Research/Clinical Labs TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CUBIST PHARMACEUTICALS, INC.
65 Hayden Avenue, Lexington, MA, 02421, US
MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES